Multiple methods have been developed to accurately measure PD-L1 expression on circulating tumor cells (CTCs), including the FDA-approved Cellsearch system [54] and reverse transcription droplet digital polymerase chain reaction (RT-ddPCR) [55], which allows for the measurement of very small amounts of RNA transcripts. Here, CD274 is linked to neoplasm.